Shanghai Haoyuan Chemexpress Co LtdSHG 688131 Stock Report

Shanghai Haoyuan Chemexpress Co. Ltd. engages in the research and development of related compounds in the development of new drugs. The company is headquartered in Shanghai, Shanghai and currently employs 2,785 full-time employees. The company went IPO on 2021-06-08. The firm's main products include molecular building blocks and tool compounds. The firm's products also include active pharmaceutical ingredients (APIs) and intermediates. The firm also provides related services such as contract research organization (CRO) service. The firm's molecular building blocks and tool compounds are applied in all stages of the drug discovery process. The firm distributes its products in domestic market and to overseas markets.